Table 5 Analysis of T cell subsets, IgM, L%, NLR, CRP and D-Dimer in early-stage (stage I & II) NSCLC patients

CD3+ (%)

69.20 (62.50，74.53)

67.10 (56.90，72.25)

0.133

CD4+ (%)

40.81 ± 11.11

28.03 ± 10.05

< 0.001

CD8+ (%)

28.46 ± 8.96

21.06 ± 7.59

0.001

CD4/CD8

1.57 ± 0.60

1.50 ± 0.78

0.712

CD16 + 56+ (%)

14.84 ± 8.09

18.23 ± 9.55

0.129

CD19+ (%)

8.70 (6.71，13.40)

10.45 (5.42，17.22)

0.936

IgM (g/L)

1.03 ± 0.40

0.95 ± 0.33

0.467

L%

18.10 (10.80，28.20)

16.00 (10.80，20.20)

0.328

NLR

3.52 (2.09，6.85)

4.28 (3.52，7.67)

0.254

CRP (mg/L)

8.03 (2.73，41.48)

14.56 (2.26，134.93)

0.307

D-Dimer (mg/L)

0.85 (0.31，2.80)

1.60 (0.74，4.55)

0.131